simendan has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, S; Guo, Z; Liu, H; Shi, Y; Zhang, C | 1 |
| Krumnikl, JJ; Metzler, H; Prenner, G; Toller, WG | 1 |
2 other study(ies) available for simendan and Lung Diseases
| Article | Year |
|---|---|
Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Caspase 3; Decanoic Acids; Disease Models, Animal; Hydrazones; Hydroxy Acids; Lung; Lung Diseases; Male; Pyridazines; Rats; Reperfusion Injury; Simendan | 2015 |
Beneficial outcome after prostaglandin-induced post-partum cardiac arrest using levosimendan and extracorporeal membrane oxygenation.
Topics: Adult; Cardiotonic Agents; Catecholamines; Cesarean Section; Drug Resistance; Extracorporeal Membrane Oxygenation; Female; Heart Arrest; Hemodynamics; Humans; Hydrazones; Lung Diseases; Postpartum Hemorrhage; Pregnancy; Prostaglandins; Pyridazines; Simendan; Treatment Outcome; Uterine Diseases | 2006 |